Skip to main content
. 2017 Sep 18;24(1):1360–1371. doi: 10.1080/10717544.2017.1375576

Figure 2.

Figure 2.

In vivo biodistribution profile of cASP orally administered, in healthy mice. (A) Fluorescence intensity images of mice whole body from 0 to 8 h. (B) Ex vivo imaging of major organs (heart, liver, spleen, lung, kidney) from 0 to 6 h. (C) Ex vivo imaging of gastrointestinal tract from 0 to 6 h.